Parexel Execs On Regulatory Harmonization, AI Impact, RWE Challenges

Opportunity For RWE In India

From the US FDA’s ISTAND Program to EU’s Melloddy Initiative, and from the global challenges of real-world data to the opportunities in India, Parexel’s EVP for Clinical Data and Digital Services, chief strategy officer and India head speak on a range of topics in this interview with the Pink Sheet.

L-R - Parexel’s Kushal Gohil (Chief Strategy Officer), Sanjay Vyas (EVP and MD for India) and Stephen Pyke (EVP, Clinical Data and Digital Services) • Source: Pink Sheet/Citeline

More from R&D

More from Pink Sheet